Greenline Partners’s Medtronic MDT Stock Holding History

Greenline Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-23,304	Closed	-$2.09M	–	404
2025 Q1	$2.09M	Hold	23,304	–	–	0.3%	70
2024 Q4	$1.86M	Hold	23,304	–	–	0.26%	73
2024 Q3	$2.1M	Hold	23,304	–	–	0.3%	66
2024 Q2	$1.8M	Hold	23,304	–	–	0.27%	72
2024 Q1	$2.03M	Hold	23,304	–	–	0.32%	62
2023 Q4	$1.92M	Hold	23,304	–	–	0.32%	64
2023 Q3	$1.83M	Hold	23,304	–	–	0.34%	61
2023 Q2	$2.05M	Sell	23,304 -300	-1%	-$25.8K	0.38%	58
2023 Q1	$1.9M	Sell	23,604 -9,399	-28%	-$766K	0.36%	62
2022 Q4	$2.56M	Sell	33,003 -2,016	-6%	-$163K	0.51%	55
2022 Q3	$2.83M	Buy	35,019 +142	+0.4%	+$12.8K	0.64%	43
2022 Q2	$3.13M	Buy	34,877 +2,239	+7%	+$227K	0.68%	41
2022 Q1	$3.62M	Hold	32,638	–	–	0.68%	44
2021 Q4	$3.38M	Sell	32,638 -9	-0%	-$1.04K	0.64%	42
2021 Q3	$4.09M	Hold	32,647	–	–	0.86%	36
2021 Q2	$4.05M	Hold	32,647	–	–	0.83%	30
2021 Q1	$3.86M	Hold	32,647	–	–	0.84%	32
2020 Q4	$3.82M	Buy	32,647 +9	+0%	+$991	0.88%	31
2020 Q3	$3.39M	Buy	+32,638	New	+$3.28M	0.86%	32

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Greenline Partners's MDT Position: Q2 2025 in Review

Greenline Partners sold out of Medtronic (MDT) in Q2 2025, closing a stake of 23,304 shares — an estimated $2.09M sold.

Greenline Partners first reported a position in MDT in Q3 2020 and held it in 19 quarters. The position peaked at $4.09M in Q3 2021. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Greenline Partners reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
Greenline Partners sold 23,304 Medtronic shares in Q2 2025, an estimated $2.09M.
Greenline Partners first reported a position in Medtronic in Q3 2020 and held it in 19 quarters.
Greenline Partners's Medtronic position peaked at $4.09M in Q3 2021.
2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Greenline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.